天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook Chinese Germany Japanese Korean

南京騰怡生物科技有限公司 Company Information

Company Name:    Nanjing Tengyi Biotechnology Co., Ltd
Tel:    025-58851786
Email:    sales@tybiochem.com
Nationality:    China
WebSite:    https://tybiochem.com/
Product List:    7328
20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74

Product List
Ispinesib 336113-53-2
4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE, 7-METHYL-2-(4-MORPHOLINYL)-9-[1-(PHENYLAMINO)ETHYL]- 663619-89-4
AT9283 896466-04-9
BMS-754807 1001350-96-4
IPA-3 42521-82-4
LJH685 1627710-50-2
Lys05 1391426-24-6
T0901317 293754-55-9
IMD-0354 978-62-1
SU 6656 330161-87-0
K02288 1431985-92-0
SF1670(PTENinhibitor) 345630-40-2
Cl-amidine TFA 1043444-18-3
CCT245737 1489389-18-5
LF3 664969-54-4
Imaradenant (AZD4635) 1321514-06-0
Apigenin 520-36-5
CM-272 1846570-31-7
TTNPB 71441-28-6
Benzenesulfonyl fluoride, 4-(2-aminoethyl)-, hydrochloride (1:1) 30827-99-7
eflornithine ,eflornithine hydrochloride hydrate 96020-91-6
OSU-03012 (AR-12) 742112-33-0
4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione 865854-05-3
Afuresertib 1047644-62-1
STF 083010 307543-71-1
IM-12 1129669-05-1
Mivebresib 1445993-26-9
MI-503 1857417-13-0
Asciminib 1492952-76-7
Mavacamten 1642288-47-8
LXH254,LXH-254 1800398-38-2
BMS-1166 1818314-88-3
6-((4-Chlorobenzyl)oxy)-3-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)-3',5'-bis(trifluoromethyl)-[1,1'-biphenyl]-2-ol 2289690-31-7
Lonafarnib 193275-84-2
Marimastat 154039-60-8
Elesclomol 488832-69-5
STAT5-IN-1 285986-31-4
Pracinostat (SB939) 929016-96-6
SRT 2104 1093403-33-8
Vorapaxar 618385-01-6
AZ20 1233339-22-4
2-D08 144707-18-6
Pifithrin-μ 64984-31-2
GW6471 880635-03-0
OSI-027 936890-98-1
Zelavespib (PU-H71) 873436-91-0
Nirogacestat 1290543-63-3
TLR2-IN-C29 363600-92-4
SR-18292 2095432-55-4
C178 329198-87-0
SR-717 2375421-09-1
Nelfinavir Mesylate 159989-65-8
2-Cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl-benzoicacid 890842-28-1
AUZ 454 853299-07-7
FPS-ZM1 945714-67-0
SGC-CBP30 1613695-14-9
AZD5582 1258392-53-8
WZB-117 1223397-11-2
E6446 dihydrochloride 1345675-25-3
GSK2982772 1622848-92-3
4-(5,6-Dimethoxybenzo[b]thiophen-2-yl)-4-oxobutanoic acid 129425-81-6
CI-994 112522-64-2
Silibinin 22888-70-6
IBMX 28822-58-4
GSK2656157 1337532-29-2
Dubermatinib 1341200-45-0
Unesbulin 1610964-64-1
Pitavastatin Calcium 147526-32-7
Lonidamine 50264-69-2
9-[(2-Hydroxyethoxy)Methyl]Guanine 59277-89-3
Benzamide, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)- 55981-09-4
PHA-665752 477575-56-7
FR 180204 865362-74-9
ML 141 71203-35-5
3',4',5,7-Tetrahydroxyflavone 491-70-3
A-1210477 1668553-26-1
Cholesterol 57-88-5
Monensin sodium salt 22373-78-0
SIRTINOL 410536-97-9
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-, sodium salt(1:1), (2S,5R,6R)- 69-52-3
Omeprazole 73590-58-6
PNU-74654 113906-27-7
N4-(9-Ethyl-9H-carbazol-3-yl)-N2-(3-Morpholin-4-yl-propyl)-pyriMidine-2,4-diaMine 1380432-32-5
TMP-269 1314890-29-3
PHA-767491 HCl 942425-68-5
4-Hexenoic acid,6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (4E)- 24280-93-1
GDC-0575 1196541-47-5
KYA1797K 1956356-56-1
Autophinib 1644443-47-9
EX229 1219739-36-2
Geldanamycin 30562-34-6
TED-347 2378626-29-8
ZM 447439 331771-20-1
PJ34 hydrochloride 344458-15-7
5'-D(ATGAAAATCAGGGTTAGG)-3', SODIUM SALT 1047953-91-2
Ruboxistaurin hydrochloride 169939-93-9
Bafetinib 859212-16-1
Carbonic Anhydrase IX/XII Inhibitor II(U-104) 178606-66-1
3-(3-Aminopropoxy)-N-(2-((3-((4-chloro-2-hydroxyphenyl)carbamoyl)naphthalen-2-yl)oxy)ethyl)-2-naphthamide hydrochloride 1433286-70-4
4'-Chloro-6-((4-chlorobenzyl)oxy)-3-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)-3'-(trifluoromethyl)-[1,1'-biphenyl]-2-ol 2289691-01-4
20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74

Copyright 2007©  ChemicalBook. All rights reserved.